COVID-19 and cardiovascular complications - preliminary results of the LATE-COVID study

Joanna Lewek1,2, Izabela Jatczak-Pawlik1,3, Marek Maciejewski2

  • 1Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.

Insights

Post-COVID-19 cardiovascular complications can be severe, particularly in patients with diabetes. Key indicators of severity include reduced ejection fraction and elevated C-reactive protein and troponin levels.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) is known to affect multiple organs, leading to various complications.
  • Cardiovascular issues are among the significant post-COVID-19 complications observed in patients.

Purpose of the Study:

  • To investigate the clinical characteristics and outcomes of cardiovascular complications following COVID-19.
  • To identify factors associated with the severity of these post-COVID-19 cardiovascular issues.

Main Methods:

  • Analysis of 51 patients admitted for potential cardiovascular complications post-COVID-19.
  • Data collection included clinical information, laboratory tests, echocardiography, and 24-hour ECG monitoring.

Main Results:

  • Severe cardiovascular complications occurred in 27.5% of hospitalized patients, typically 1-4 months after recovery.
  • Patients with severe complications showed higher rates of diabetes, decreased ejection fraction, elevated heart rate, C-reactive protein, and troponin T.
  • Dyspnea and exercise intolerance were more prevalent in those with severe complications.

Conclusions:

  • Diabetes, elevated C-reactive protein (CRP), troponin levels, and reduced left ventricular ejection fraction are linked to severe cardiovascular complications after COVID-19.
  • Heart rate variability parameters also correlate with the severity of post-COVID-19 cardiovascular sequelae.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
105
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
568
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
141
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
135
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
105